Related Experiment Videos
Enzyme-linked immunosorbent assay for anti-streptococcal protoplast membrane antibodies
Abstract:
An enzyme-linked immunosorbent assay is described for the quantitative determination of circulating antibodies to streptococcal protoplast membranes (SPM) in human sera. The assay was used to study the prevalence of antibodies to SPM of M types 6 and 12 Streptococcus pyogenes in sera from 55 patients with recent streptococcal infection, and 30 normal individuals without clinical evidence of streptococcal infection. No correlation was found between levels of anti-SPM antibodies and ASO titres. However, in serial serum samples from one patient with uncomplicated streptococcal sore throat, it was possible to demonstrate that the increase in the level of anti-SPM antibody paralleled the rise in ASO titre. The anti-SPM antibody level and the ASO titre in this patient persisted throughout a six-month period of follow-up.
Insights
A new enzyme-linked immunosorbent assay quantifies antibodies to streptococcal protoplast membranes (SPM). This study found no direct correlation with ASO titres but observed parallel increases in anti-SPM antibodies and ASO titres during infection.
Area of Science:
- Immunology
- Microbiology
- Diagnostic Assays
Background:
- Streptococcus pyogenes infections are common, necessitating reliable diagnostic tools.
- Circulating antibodies can indicate recent or active streptococcal infections.
- Understanding antibody responses to different bacterial components is crucial for diagnostics.
Purpose of the Study:
- To develop and validate an enzyme-linked immunosorbent assay (ELISA) for quantifying antibodies against streptococcal protoplast membranes (SPM).
- To investigate the prevalence of anti-SPM antibodies in patients with recent streptococcal infections compared to healthy individuals.
- To explore the relationship between anti-SPM antibody levels and anti-streptolysin O (ASO) titres.
Main Methods:
- Development of an enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of circulating antibodies to streptococcal protoplast membranes (SPM).
- Analysis of human sera from 55 patients with recent Streptococcus pyogenes infections and 30 healthy controls.
- Comparison of anti-SPM antibody levels with standard anti-streptolysin O (ASO) titres.
Main Results:
- The developed ELISA successfully quantified antibodies to SPM of Streptococcus pyogenes M types 6 and 12.
- No significant correlation was observed between anti-SPM antibody levels and ASO titres in the patient cohort.
- In a case study, a rise in anti-SPM antibody levels paralleled the increase in ASO titre during an uncomplicated streptococcal sore throat.
Conclusions:
- The study presents a novel ELISA for detecting anti-SPM antibodies, offering a potential new diagnostic marker.
- Anti-SPM antibodies may provide complementary information to ASO titres in diagnosing streptococcal infections.
- Further research is warranted to establish the clinical utility and diagnostic performance of anti-SPM antibody detection.